A major drug and firearm investigation in one Chicago neighborhood leads to federal charges against seven people. Here's what ...

Technology will soon make it possible to develop cheap, widely accessible psychoactive substances that are not harmful in the ...

The Biden-Harris Administration is listening.” Some critics argue the DEA shouldn't change course on marijuana, saying rescheduling isn't necessary and could lead to harmful side effects.

MIRA is advancing complementary non-opioid therapies for two of the largest pain markets MIAMI, FLORIDA / ACCESS Newswire / ...

MIRA Pharmaceuticals (NASDAQ: MIRA) shares soared 50.8% to $1.87 in after-hours trading on Wednesday after announcing promising results for their non-opioid pain drug, Mira-55, and plans for future ...

In another sign that marijuana reform may be taking a back seat amid competing political priorities during the second Trump ...

Congressional attention has drifted toward adult-use legalization and the chaotic hemp-derived cannabinoid market, leaving ...

The DEA's alleged resistance to cannabis rescheduling under the Biden administration leaves reform efforts stalled. Read more here.

DEA Judge suspends marijuana rescheduling hearing, delaying the process amidst allegations of collusion. Advocates hope the Trump administration will provide fresh start.